Related Experiment Video
Updated: Mar 4, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune
Bas C Mourik1, Erik Lubberts2, Jurriaan E M de Steenwinkel1
1Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands.
The classical view of tuberculosis (TB) immunity is challenged by new research. Type 1 interferons and Th17 responses, studied in autoimmune diseases, offer new insights into TB pathogenesis.
Area of Science:
- Immunology
- Infectious Diseases
- Autoimmune Diseases
Background:
- The traditional Th1-centric model of tuberculosis (TB) immunity is insufficient, as vaccine strategies targeting Th1 responses have yielded poor results.
- Increased lung interferon-gamma (IFN-γ) levels in preclinical TB models exacerbate host damage rather than control the pathogen.
- Type 1 interferon signaling and altered Th17 responses are linked to active TB, but their precise roles in disease progression require elucidation.
Purpose of the Study:
- To review the roles of type 1 interferons and Th17 immunity in TB pathogenesis.
- To explore interactions between type 1 interferon and Th17 responses observed in systemic autoimmune diseases (AID).
- To evaluate the relevance of these AID-related pathways for a novel perspective on TB research.
Main Methods:
- Literature review focusing on type 1 interferons, Th17 immunity, and their interactions in TB and AID.
- Analysis of functional interactions including effects on monocytes, B-cell activating factor production, and tertiary lymphoid structures.
- Discussion of the roles of GM-CSF-secreting Th17.1 cells, neutrophils, and follicular helper T-cells.
Main Results:
- Type 1 interferons and Th17 immunity have complex roles in TB, potentially contributing to pathogenesis.
- Interactions between type 1 interferon and IL-17 signaling influence monocyte and neutrophil functions.
- Synergistic effects of IL-17 and type 1 interferons are observed in tertiary lymphoid structure formation and follicular helper T-cell responses.
Conclusions:
- Rethinking TB immunity beyond the classical Th1 paradigm is necessary.
- Investigating type 1 interferon and Th17 pathways, informed by autoimmune disease research, offers new avenues for understanding TB.
- These insights may lead to novel therapeutic and vaccine strategies for tuberculosis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

